Cue Biopharma (CUE) vs Satellos Bioscience (MSLE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Satellos Bioscience (MSLE) has outperformed Cue Biopharma (CUE) over the past year, gaining 5.4% versus a loss of 0.2%. Over five years, MSLE leads with a -48.9% price change compared with -94.0% for CUE. Cue Biopharma is the larger company by market cap ($163.5 million vs $161.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CUE | MSLE |
|---|---|---|
| Share price | $22.51 | $7.63 |
| Market cap | $163.52M | $161.88M |
| 1-day change | -2.72% | +1.19% |
| YTD return | +146.01% | +29.76% |
| 1-year return | -0.22% | +5.44% |
| 5-year return | -94.04% | -48.93% |
| EPS (TTM) | $-29.59 | $-1.95 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $45.50 | $13.40 |
| 52-week low | $4.98 | $5.30 |
| Distance from 52-week high | -50.53% | -43.04% |
| Average volume | 268.50K | 58.07K |
| Shares outstanding | 7.26M | 21.22M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CUE vs MSLE FAQ
Which is bigger, Cue Biopharma or Satellos Bioscience?
Cue Biopharma (CUE) is larger, with a market capitalization of $163.52M compared with $161.88M for Satellos Bioscience (MSLE).
Which stock has performed better over the past year, CUE or MSLE?
MSLE returned +5.44% over the past 12 months, compared with -0.22% for CUE (price return, excluding dividends). Past performance does not predict future results.
Are Cue Biopharma and Satellos Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.